Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

被引：69
|
作者：
Zugmaier, G. [1 ]
Topp, M. S. [2 ,3 ]
Alekar, S. [4 ]
Viardot, A. [5 ]
Horst, H-A [6 ,7 ]
Neumann, S. [6 ,7 ]
Stelljes, M. [8 ]
Bargou, R. C. [3 ]
Goebeler, M. [3 ]
Wessiepe, D. [9 ]
Degenhard, E. [1 ]
Goekbuget, N. [10 ]
Klinger, M. [1 ]
机构：
[1] Amgen Res Munich GmbH, Munich, Germany
[2] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[3] Univ Klinikum Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
[5] Univ Ulm, Dept Med 3, D-89069 Ulm, Germany
[6] City Hosp, Dept Med 2, Kiel, Germany
[7] Univ Hosp Schleswig Holstein, Kiel, Germany
[8] Univ Munster, Bone Marrow Transplantat Ctr, D-48149 Munster, Germany
[9] Metronomia GmbH, Munich, Germany
[10] Goethe Univ Frankfurt, Ctr Internal Med, Frankfurt, Germany
来源：
BLOOD CANCER JOURNAL | 2014年 / 4卷
关键词：
STEM-CELL TRANSPLANTATION; ENGAGING ANTIBODY; FREE SURVIVAL; RITUXIMAB; LYMPHOMA; HYPOGAMMAGLOBULINEMIA; LINEAGE;
D O I：
10.1038/bcj.2014.64
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e244 / e244
页数：4
相关论文
共 50 条
  • [31] LONG-TERM FOLLOW-UP OF PATIENTS TREATED FOR BASEDOWS DISEASE
    CHAVRIER, B
    BERTHEZENE, F
    MORNEX, R
    ANNALES D ENDOCRINOLOGIE, 1974, 35 (01) : 72 - 73
  • [32] SERUM IMMUNOGLOBULIN LEVELS IN CHILDHOOD HODGKINS-DISEASE - EFFECT OF SPLENECTOMY AND LONG-TERM FOLLOW-UP
    WALZER, PD
    ARMSTRONG, D
    WEISMAN, P
    TAN, C
    CANCER, 1980, 45 (08) : 2084 - 2089
  • [33] Detection and quantification of minimal residual disease in childhood B-precursor acute lymphoblastic leukemia by limiting dilution and PCR application.
    deHaas, V
    Verhagen, OJHM
    vandenBerg, H
    vondemBorne, AEGK
    vanderSchoot, CE
    BLOOD, 1997, 90 (10) : 813 - 813
  • [34] A LONG-TERM CLINICAL FOLLOW-UP OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY REGIMENS
    HAGHBIN, M
    TAN, CC
    CLARKSON, BD
    THALER, HT
    PASSE, S
    BURCHENAL, J
    MURPHY, ML
    CANCER, 1980, 46 (02) : 241 - 252
  • [35] Blinatumomab in B-Cell Acute Lymphoblastic Leukemia with Positive Minimal Residual Disease: Initial Results of a Phase II Trial
    Maiti, Abhishek
    Kantarjian, Hagop M.
    Short, Nicholas J.
    Khouri, Maria
    Takahashi, Koichi
    Ohanian, Maro
    Borthakur, Gautam
    Konopleva, Marina
    Daver, Naval
    Estrov, Zeev
    Alvarado, Yesid
    Thompson, Philip A.
    Jain, Nitin
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Cholick, Carissa N.
    Khouri, Rita
    O'Brien, Susan M.
    Jabbour, Elias J.
    BLOOD, 2017, 130
  • [36] Long-term follow-up and infectious complications of therapy for acute lymphoblastic leukemia in children
    Nakamura, S
    Gelber, RD
    Blattner, S
    Sallan, SE
    Chanock, SJ
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 2000, 6 (05): : 321 - 330
  • [37] Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease
    Yhim, Ho-Young
    Lee, Na Ri
    Song, Eun-Kee
    Yim, Chang-Yeol
    Jeon, So Yeon
    Lee, Bohee
    Kim, Jeong-A
    Kim, Hee Sun
    Cho, Eun Hae
    Kwak, Jae-Yong
    BLOOD, 2014, 124 (21)
  • [38] Characterization of Fever, Infection, and Cytokine Release Syndrome (CRS) in Adult Patients with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab
    Patel, Yogin B.
    Kantarjian, Hagop M.
    Thomas, Deborah
    O'Brien, Susan
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Konopleva, Marina
    Jain, Nitin
    Garris, Rebecca
    Autry, Jane
    Jabbour, Elias
    BLOOD, 2015, 126 (23)
  • [39] Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes
    Huang, Ying-Jung
    Coustan-Smith, Elaine
    Kao, Hsiao-Wen
    Liu, Hsi-Che
    Chen, Shih-Hsiang
    Hsiao, Chih-Cheng
    Yang, Chao-Ping
    Jaing, Tang-Her
    Yeh, Ting-Chi
    Kuo, Ming-Chung
    Lai, Chang-Liang
    Chang, Chia-Hui
    Campana, Dario
    Liang, Der-Cherng
    Shih, Lee-Yung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (10) : 774 - 781
  • [40] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia (vol 131, pg 1522, 2018)
    Gokbuget, N.
    Dombret, H.
    Bonifacio, M.
    BLOOD, 2019, 133 (24) : 2625 - 2625
12345